|Slideshows|October 2, 2019

5 criteria for diagnosing ADHD

Author(s)Pat F. Bass III, MD, MS, MPH, David O Childers Jr., MD

When determining whether a diagnosis of attention-deficit/hyperactivity disorder (ADHD) is the correct diagnosis, here are 5 important criteria to consider.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Subscribe

Related Content

Supporting the language development of deaf and hard of hearing children: A clinical guide for pediatric providers

BySydney Peters, MD ,Shazia Siddiqi, MD, MPH

July 15th 2026

Cyclosporiasis in 2026: A clinical update for pediatricians

ByContemporary Pediatrics Staff

July 15th 2026

Trisha Torga, MD, urges pediatricians to address social media skincare trends with adolescents

ByTrisha Torga, MD

July 15th 2026

Q&A: Keisha Gibson, MD, discusses the FDA priority review of obinutuzumab for pediatric INS

ByKeisha L. Gibson, MD, MPH

July 14th 2026

Trisha Torga, MD, on how social media skincare trends may be driving skin irritation in adolescents

ByTrisha Torga, MD

July 14th 2026

Latest CME

Video

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

5 criteria for diagnosing ADHD

Related Content

Supporting the language development of deaf and hard of hearing children: A clinical guide for pediatric providers

Cyclosporiasis in 2026: A clinical update for pediatricians

Trisha Torga, MD, urges pediatricians to address social media skincare trends with adolescents

Q&A: Keisha Gibson, MD, discusses the FDA priority review of obinutuzumab for pediatric INS

Trisha Torga, MD, on how social media skincare trends may be driving skin irritation in adolescents

Latest CME

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Trending on Contemporary Pediatrics

Cyclosporiasis in 2026: A clinical update for pediatricians

FDA presses infant formula makers to tighten supplier oversight after botulism and cereulide events

Q&A: Keisha Gibson, MD, discusses the FDA priority review of obinutuzumab for pediatric INS

Nonreceipt of newborn intramuscular vitamin K linked to doubled bleeding risk

Trisha Torga, MD, urges pediatricians to address social media skincare trends with adolescents